You are here

SARC007

Completed
Phase 2 Trial of perifosine in patients with chemo-insensitive Sarcomas
Type of Sarcoma: 
Chondrosarcoma, extra-skeletal myxoid chondrosarcoma or alveolar soft part sarcoma
Drug: 
Perifosine
Accrual Status: 
Closed
Overall Study Principal Investigator: 

Dejka Araujo, MD
MD Anderson Cancer Center

For more information about this trial and open sites: